PPARG Antikörper (AA 254-478)
Kurzübersicht für PPARG Antikörper (AA 254-478) (ABIN7141816)
Target
Alle PPARG Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 254-478
-
Kreuzreaktivität
- Hund, Human, Maus, Schwein, Ratte
-
Aufreinigung
- Affinity purified
-
Immunogen
- Recombinant fragment, corresponding to amino acids 254-478aa of human PPARG(C-terminus).
-
Isotyp
- IgG1, IgG1 kappa
-
-
-
-
Applikationshinweise
- Recommended dilution:WB:1:500-1:5000,ICC:1:50-1:200,
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- Purified mouse monoclonal in buffer containing 0.1M Tris-Glycine ( pH 7.4, 150 mM NaCl) with 0.2 % sodium azide, 50 %,glycerol
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C,-80 °C
-
Informationen zur Lagerung
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
-
- PPARG (Peroxisome Proliferator-Activated Receptor gamma (PPARG))
-
Andere Bezeichnung
- PPARG
-
Hintergrund
- Peroxisome proliferator-activated receptor gamma PPAR gamma PPAR-gamma nuclear receptor subfamily 1 group C member 3 peroxisome proliferator-activated receptor gamma 1 peroxisome proliferator-activated nuclear receptor gamma variant
-
UniProt
- P37231
-
Pathways
- MAPK Signalweg, Nuclear Receptor Transcription Pathway, Steroid Hormone Mediated Signaling Pathway, Negative Regulation of Hormone Secretion, Carbohydrate Homeostasis, Regulation of Lipid Metabolism by PPARalpha, Positive Regulation of Endopeptidase Activity, Brown Fat Cell Differentiation, Positive Regulation of fat Cell Differentiation
Target
-